Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa
The 'Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa' program, under the Global Health EDCTP3 Joint Undertaking, aims to combat infectious diseases in sub-Saharan Africa. This initiative focuses on developing and integrating new or improved interventions, particularly through clinical trials and implementation research, while fostering strong international partnerships and building local capacity.
Who is Funded
This section provides an overview of the eligible participants, the geographical scope where projects must be implemented, and the core objectives the program seeks to achieve. It details the specific types of organizations that can apply, the countries and regions that are covered by the funding, and the overarching goals designed to reduce the burden of infectious diseases.
What is Funded
This section outlines the types of projects, thematic areas, and activities eligible for funding, clarifying the specific focus on Neglected Tropical Diseases (NTDs) therapeutics. It specifies the diseases covered, the research stages supported, and encourages a multidisciplinary approach to integrate pharmaceutical interventions into public health systems.
Type and Scope of Funding
This section provides details on the nature of financial support, specifying that funding is provided in the form of grants. It outlines the funding amounts available per project under this topic, ensuring clarity on the financial parameters for potential applicants.
Conditions and Requirements
This section outlines the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to throughout the application and project implementation phases. It details requirements for consortium composition, financial stipulations, and other critical provisions to ensure compliance and effective project execution.
Application Procedure
This section outlines the application submission and evaluation process for the 'Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa' program. It details the two-stage procedure, key deadlines, and the criteria used for evaluating proposals.
Legal Basis
This section details the fundamental legal and official documents that establish and govern the 'Accelerating development and integration of therapeutics against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa' funding program, along with information on how to access these official texts.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
5,000,000 €
Allocated Budget:
22,000,000 €
Award Channel:
Framework Programme Call
Region:
European Union Member States, Overseas Countries and Territories (Aruba, Bonaire, Curaçao, French Polynesia, French Southern and Antarctic Territories, Greenland, New Caledonia, Saba, Saint Barthélemy, Sint Eustatius, Sint Maarten, St. Pierre and Miquelon, Wallis and Futuna Islands), Horizon Europe Associated Countries (Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Norway, Serbia, Tunisia, Turkey, Ukraine, United Kingdom), Canada, Morocco, and sub-Saharan African countries (Benin, Burkina Faso, Cameroon, Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, The Gambia, Ghana, Guinea-Bissau, Guinea-Conakry, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Republic of the Congo, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Tanzania, Uganda, Zambia, Zimbabwe). Research must involve vulnerable groups in sub-Saharan Africa.
Sectors:
Healthcare, Research and Development, Pharmaceutical Industry
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Implementation, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
Global Health EDCTP3 Joint Undertaking
Managed By:
Global Health EDCTP3 Joint Undertaking
Additional Partners:
Team Europe Initiative on Manufacturing and health products (TEI-MAV+)
Website: